HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Accounts Payables (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Accounts Payables came in at $33.6 million in Q2 2026, down 23.05% year-over-year from $43.7 million in Q2 2025, and down 26.11% quarter-over-quarter from $45.5 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Accounts Payables (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Accounts Payables for 12 consecutive years, with $33.6 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Accounts Payables fell 23.05% year-over-year to $33.6 million in Q2 2026; TTM through Jun 2026 was $33.6 million, a 23.05% decrease from a year earlier, with the FY2025 full-year figure at $45.5 million, changed N/A from the prior year.
  • Accounts Payables was $33.6 million for Q2 2026 at HUTCHMED (China), down from $45.5 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $71.1 million in Q4 2022 and troughed at $33.6 million in Q2 2026.
  • A 5-year average of $49.0 million and a median of $45.5 million in 2025 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables surged 78.88% in 2022 and retreated 23.05% in 2026, its largest moves.
  • Over 5 years, Accounts Payables stood at $71.1 million in 2022, then declined by 23.26% to $54.6 million in 2023, then fell by 20.48% to $43.4 million in 2024, then advanced by 4.92% to $45.5 million in 2025, then fell by 26.11% to $33.6 million in 2026.
  • The last three Accounts Payables figures came in at $33.6 million (Q2 2026), $45.5 million (Q4 2025), and $43.7 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 210.97 Bn 196.98 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 180.98 Bn 177.80 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 132.09 Bn 124.24 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 82.56 Bn 74.57 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 61.71 Bn 56.53 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.60 Bn 49.46 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 34.02 Bn 30.71 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.25 Bn 29.97 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 29.76 Bn 29.76 Bn 1.16 Mn 25.08 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 33.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.65 Mn
Dec 31, 2025 45.53 Mn
Jun 30, 2025 43.73 Mn
Jun 30, 2024 43.40 Mn
Jun 30, 2023 54.58 Mn
Dec 31, 2022 71.12 Mn
Jun 30, 2022 51.01 Mn
Dec 31, 2021 41.18 Mn
Jun 30, 2021 28.51 Mn
Mar 31, 2021 28.64 Mn
Dec 31, 2020 31.61 Mn
Jun 30, 2020 25.87 Mn
Dec 31, 2019 23.96 Mn
Sep 30, 2019 23.03 Mn
Jun 30, 2019 26.15 Mn
Mar 31, 2019 30.76 Mn
Dec 31, 2018 25.63 Mn
Jun 30, 2018 19.31 Mn
Dec 31, 2017 -11.17 Mn
Jun 30, 2017 27.26 Mn